Systemic adverse reactions to prostaglandin F2 (PGF2 alpha, dinoprostone, prostin F2 alpha, prostalmon F).
Prostaglandins are mainly used in clinical medicine for midterm abortion and to terminate pregnancy. Systemic adverse reactions include nausea and vomiting, which occur in approximately half of the patients and, to a lesser extent, diarrhea. Although bronchospasm occurs infrequently, PGF2 should be avoided in asthmatics. Cardiorespiratory failure culminating in prolonged coma and death has been reported. Moreover, convulsions and EEG changes have been observed in a comparatively small number of cases.
D000019:Abortifacient Agents / Q000009:adverse effects*; D000028:Abortion, Induced; D001986:Bronchial Spasm / Q000139:chemically induced; D003967:Diarrhea / Q000139:chemically induced; D015237:Dinoprost; D015232:Dinoprostone / Q000031:analogs & derivatives; D005260:Female; D006323:Heart Arrest / Q000139:chemically induced; D006801:Humans; D011247:Pregnancy; D011453:Prostaglandins / Q000009:adverse effects*; D011458:Prostaglandins E / Q000009:adverse effects; D011459:Prostaglandins E, Synthetic / Q000009:adverse effects; D011460:Prostaglandins F / Q000009:adverse effects; D012640:Seizures / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000019:Abortifacient Agents; D011453:Prostaglandins; D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D011460:Prostaglandins F; C016767:sulprostone; D015237:Dinoprost; D015232:Dinoprostone